Tags |
|
|
Links |
|
|
Top Articles - Stock Investing - Merck Tries New Tactic To Sell Vaccination Drug - Force Girls To Take It
Giant Merck, a major growth stock for 50 years has seen that growth slowing down along with Pfizer and the rest of the major drug companies. Merck has latched onto a new strategy to build sales again, but it’s not just Merck and Pfizer that are suffering. The major pharmaceutical companies around the world are in a slowdown,
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
and panic is starting to set into the executive suite.
Some of these companies are now doing in the tens of billions of dollars per year in sales. The drug industry is the most profitable industry in the world today bar none. The returns on invested capital, and profit margins are extraordinary
President Bush, and the the
Some of these companies are now doing in the tens of billions of dollars per year in sales. The drug industry is the most profitable industry in the world today bar none. The returns on invested capital, and profit margins are extraordinary
President Bush, and the the
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
n Republican Congress created the prescription drug program for seniors in an attempt to reverse the tide for these companies. The drug manufacturers have been a major contributor to the Republican Party for more than a decade. Both Merck, and Pfizer have begun downsizing their sales forces in response to the slow down.
The
The
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
problem for these companies is that they have gotten so big in terms of their sales bases, that they are having great difficulty generating new drugs on a scale that can compensate for the slowdown of their current portfolio of drugs. In addition many of these fabulous drugs currently being sold are going off patent protecti
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
on, and that means a collapse in sales revenues. Once the generics take over, than it’s over for the original creator of the drug.
What has Merck done NOW?
Merck has created a new cervical-cancer vaccine. The American Cancer Society tells us that a little more than 11000 women this year will be told by their doctors that t
What has Merck done NOW?
Merck has created a new cervical-cancer vaccine. The American Cancer Society tells us that a little more than 11000 women this year will be told by their doctors that t
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
hey have this terrible disease. What’s worse is that more than 3500 of those women will eventually succumb to it.
Let’s put this in perspective. About 180,000 women this year will be told they have breast cancer. About 40,000 of these previously diagnosed women will eventually die from breast cancer, and its complications.
Let’s put this in perspective. About 180,000 women this year will be told they have breast cancer. About 40,000 of these previously diagnosed women will eventually die from breast cancer, and its complications.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
etween 8 times and 10 times the number of women who die from breast cancer, will die from heart disease this year. As you know breast cancer gets all the publicity compared to the other two diseases.
This new anti cervical-cancer vaccine is a wonderful creation,and everyone at Merck who participated in its creation should f
This new anti cervical-cancer vaccine is a wonderful creation,and everyone at Merck who participated in its creation should f
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
eel great pride in their work. What about the executives, and marketing people at Merck. Well, that’s a different story. Merck has decided to attempt to force the use of this vaccine onto every female pre-teenager, and teenager in America. They are pulling out all the stops in an attempt to influence every legislator they ca
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n find to mandate this vaccination be given to children regardless of their parent’s wishes.
Merck got TEXAS on board first
Could you believe it? Merck got Texas Governor Rick Perry to sign an executive order. Such an order negates the need for the Texas legislature to get involved. This order will require every young girl
Merck got TEXAS on board first
Could you believe it? Merck got Texas Governor Rick Perry to sign an executive order. Such an order negates the need for the Texas legislature to get involved. This order will require every young girl
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
in Texas to receive the Merck vaccination Gardasil at $360 for three shots of the vaccine, and yes all three are needed. You are probably aware that there is a measles-mumps vaccine that has been on the market for years. The measles shot costs only $43 per dose by comparison.
The way the deal works in Texas is that unless y
The way the deal works in Texas is that unless y
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ou can demonstrate proof that you have taken the shots, you are not going to be allowed to go to school. At the moment it looks like your health insurance is going to pick up the cost, but of course there are millions upon millions of uninsured young people in this country. Who is going to pay for them? Apparently a former C
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
hief of Staff to Governor Perry is a lobbyist for Merck, which is the same thing as saying she works for Merck, isn’t it. It’s amazing what a couple of dollars paid to a lobbyist can achieve.
Merck hiring lobbyists EVERYWHERE
When Merck’s back is to the wall, Merck knows how to respond. Merck is feeling the heat from a num
Merck hiring lobbyists EVERYWHERE
When Merck’s back is to the wall, Merck knows how to respond. Merck is feeling the heat from a num
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
er of drugs going off patent, and is therefore pulling out all the stops to systematically have each state mandate the use of this vaccine. The states that are currently considering forcing pre-teenage girls to take this vaccine are:
California Maine
Colorado Michigan
Connecticut Minnesota
Distric
California Maine
Colorado Michigan
Connecticut Minnesota
Distric
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
t of Columbia Mississippi
Florida New Jersey
Hawaii New Mexico
Illinois Oklahoma
Indiana South Carolina
Kansas Texas (DONE)
Kentucky Virginia
The question now becomes how many lobbyists will Merck hire, and how many legislators will receive political contributions in
Florida New Jersey
Hawaii New Mexico
Illinois Oklahoma
Indiana South Carolina
Kansas Texas (DONE)
Kentucky Virginia
The question now becomes how many lobbyists will Merck hire, and how many legislators will receive political contributions in
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
order to create state mandated programs that will result in billions of dollars of this vaccine being sold. There is also the issue of the safety of the vaccine.
When the clinical trials were done, the participants were mostly older women. Only a small minority of the participants were teenagers, yet teenagers are the targ
When the clinical trials were done, the participants were mostly older women. Only a small minority of the participants were teenagers, yet teenagers are the targ
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
t market. Without a much broader test of the teenage market, it may be too early to tell if there is a problem. The vaccine is being rolled out in massive quantities in the interim.
Merck and the hit major drug manufacturers are in a state of decline. Their in-house research laboratories can no longer create the drug stream
Merck and the hit major drug manufacturers are in a state of decline. Their in-house research laboratories can no longer create the drug stream
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
that is necessary to sustain them at their current levels. They are also cutting drug reps by the thousands. These are the good looking men and women with master’s degrees that know more about these drugs than the doctors who prescribe them. They visit doctors incessantly, buying them lunches, giving away pads, pens, and gi
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
fts in an attempt to convince the good doctor why he should be prescribing certain drugs.
The growth ahead seems to be in the young and middle stage biotech companies that do their research differently than Big Pharma. The biotech research facilities are routinely located in direct vicinity of major college campuses which a
The growth ahead seems to be in the young and middle stage biotech companies that do their research differently than Big Pharma. The biotech research facilities are routinely located in direct vicinity of major college campuses which a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
e receiving billions of dollars of funding from the taxpayer through the National Institute of Health.
If Big Pharma is to effectively compete against the upstart biotech firms, than companies like Merck, Pfizer, and the others will have to continue to cut costs, and exert their political power in an attempt to align their
If Big Pharma is to effectively compete against the upstart biotech firms, than companies like Merck, Pfizer, and the others will have to continue to cut costs, and exert their political power in an attempt to align their
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
goals with the goals of the federal government. After all, the largest user of drugs in the United States is Medicare / Medicaid recipients, and then the Veterans Administration. It looks like the next year or two is going to be mighty interesting for the old line drug manufacturers. Stay tune for more.
Goodbye and Good Luc
Goodbye and Good Luc
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102250/toparticles-Stock-Investing--Merck-Tries-New-Tactic-To-Sell-Vaccination-Drug--Force-Girls-To-Take-It.html">Stock Investing - Merck Tries New Tactic To Sell Vaccination Drug - Force Girls To Take It</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102250/toparticles-Stock-Investing--Merck-Tries-New-Tactic-To-Sell-Vaccination-Drug--Force-Girls-To-Take-It.html]Stock Investing - Merck Tries New Tactic To Sell Vaccination Drug - Force Girls To Take It[/url]
Related Articles:
What to Expect From a Top Flight Trade Show Exhibit Company
Ten Tips to Help You In Your Pursuit of Happiness
Bookmark it:
|